132 related articles for article (PubMed ID: 11564592)
1. Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?
Mijch AM; Hoy J; Watson K; Dunne A; Crowe S; Wesselingh SL
J Clin Virol; 2001 Oct; 22(3):271-8. PubMed ID: 11564592
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.
Palumbo PE; Raskino C; Fiscus S; Pahwa S; Fowler MG; Spector SA; Englund JA; Baker CJ
JAMA; 1998 Mar; 279(10):756-61. PubMed ID: 9508151
[TBL] [Abstract][Full Text] [Related]
3. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
[TBL] [Abstract][Full Text] [Related]
4. Outcomes following detection of low level plasma HIV RNA in HIV-infected patients previously virologically suppressed on antiretroviral therapy: a retrospective observational study.
Warren AM; Cheng AC; Watson K; Lewin SR; Hoy JF
Sex Health; 2017 Jun; 14(3):238-243. PubMed ID: 28445685
[TBL] [Abstract][Full Text] [Related]
5. Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
Phillips AN; Eron J; Bartlett J; Kuritzkes DR; Johnson VA; Gilbert C; Johnson J; Keller A; Hill AM
AIDS; 1997 Feb; 11(2):169-75. PubMed ID: 9030363
[TBL] [Abstract][Full Text] [Related]
6. Short communication: Lower baseline CD4 count is associated with a greater propensity toward virological failure in a cohort of South African HIV patients.
Costiniuk CT; Sigal A; Jenabian MA; Nijs P; Wilson D
AIDS Res Hum Retroviruses; 2014 Jun; 30(6):531-4. PubMed ID: 24803320
[TBL] [Abstract][Full Text] [Related]
7. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
[TBL] [Abstract][Full Text] [Related]
8. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
Brumme ZL; Chan KJ; Dong WW; Mo T; Wynhoven B; Hogg RS; Montaner JS; O'Shaughnessy MV; Harrigan PR
AIDS; 2002 Sep; 16(14):1929-33. PubMed ID: 12351953
[TBL] [Abstract][Full Text] [Related]
9. Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.
Bratt G; Karlsson A; Leandersson AC; Albert J; Wahren B; Sandström E
AIDS; 1998 Nov; 12(16):2193-202. PubMed ID: 9833861
[TBL] [Abstract][Full Text] [Related]
10. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
11. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.
Deeks SG; Hecht FM; Swanson M; Elbeik T; Loftus R; Cohen PT; Grant RM
AIDS; 1999 Apr; 13(6):F35-43. PubMed ID: 10397555
[TBL] [Abstract][Full Text] [Related]
12. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
13. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection.
Cozzi Lepri A; Katzenstein TL; Ullum H; Phillips AN; Skinhøj P; Gerstoft J; Pedersen BK
AIDS; 1998 Sep; 12(13):1639-43. PubMed ID: 9764783
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome.
Valdez H; Lederman MM; Woolley I; Walker CJ; Vernon LT; Hise A; Gripshover BM
Arch Intern Med; 1999 Aug 9-23; 159(15):1771-6. PubMed ID: 10448781
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
16. Experience with nevirapine in previously treated HIV-1-infected individuals.
Wit FW;
Antivir Ther; 2000 Dec; 5(4):257-66. PubMed ID: 11142620
[TBL] [Abstract][Full Text] [Related]
17. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
Hughes MD; Johnson VA; Hirsch MS; Bremer JW; Elbeik T; Erice A; Kuritzkes DR; Scott WA; Spector SA; Basgoz N; Fischl MA; D'Aquila RT
Ann Intern Med; 1997 Jun; 126(12):929-38. PubMed ID: 9182469
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of antiretrovirals for people with HIV.
Kredo T; Van der Walt JS; Siegfried N; Cohen K
Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
[TBL] [Abstract][Full Text] [Related]
19. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
O'Brien WA; Hartigan PM; Daar ES; Simberkoff MS; Hamilton JD
Ann Intern Med; 1997 Jun; 126(12):939-45. PubMed ID: 9182470
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.
d'Arminio Monforte A; Testa L; Adorni F; Chiesa E; Bini T; Moscatelli GC; Abeli C; Rusconi S; Sollima S; Balotta C; Musicco M; Galli M; Moroni M
AIDS; 1998 Sep; 12(13):1631-7. PubMed ID: 9764782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
